Correlation Between miR-497-5p Expression With Clinicopathological Characteristics and Prognosis in Patients With Breast Cancer

  • 0Department of Hematology and Blood and Marrow Transplantation.

Summary

This summary is machine-generated.

Low expression of miR-497-5p in breast cancer tissues is linked to poorer prognosis and increased mortality risk. This microRNA serves as an independent predictor of death in breast cancer patients.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Breast cancer (BC) is a heterogeneous disease with diverse biological and histological features.
  • MicroRNAs (miRNAs) play critical roles in cancer development and progression, influencing patient prognosis.
  • Understanding specific miRNA roles, like miR-497-5p, is crucial for improving breast cancer management.

Purpose Of The Study

  • To investigate the association between miR-497-5p expression and clinicopathological characteristics in breast cancer patients.
  • To evaluate the prognostic value of miR-497-5p in predicting overall survival in breast cancer.
  • To determine if miR-497-5p functions as an independent risk factor for mortality in breast cancer.

Main Methods

  • Quantitative analysis of miR-497-5p expression in 140 breast cancer tissues and adjacent normal tissues using reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
  • Correlation analysis between miR-497-5p expression levels and clinicopathological features (age, tumor size, grade, stage, lymph node metastasis).
  • Survival analysis and multivariate Cox regression modeling to assess the impact of miR-497-5p on patient prognosis and its role as an independent risk factor for death.

Main Results

  • miR-497-5p was significantly downregulated in breast cancer tissues compared to normal adjacent tissues.
  • Lower miR-497-5p expression correlated with larger tumor size, advanced clinical stage, and lymph node metastasis.
  • Patients with low miR-497-5p expression exhibited significantly decreased overall survival.

Conclusions

  • Downregulation of miR-497-5p in breast cancer tissues is associated with adverse clinicopathological features.
  • Low miR-497-5p expression is a significant predictor of poor prognosis and reduced survival in breast cancer patients.
  • miR-497-5p represents an independent risk factor for mortality in breast cancer, highlighting its potential as a therapeutic target or biomarker.